Skip to main content

Table 2 ECP and cytokine concentrations before and after treatment with montelukast.

From: Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: Effect on eosinophil density and activation in relation to pharmacokinetics

  Pre-treatment Post-treatment
ECP 10.6 ± 6.8 12.2 ± 9.0
IL-4 10.5 ± 5.7 11.7 ± 9.7
IL-5 1.8 ± 1.2 2.0 ± 2.1
IL-8 5.5 ± 7.8 8.5 ± 14.2
MCP-1 277.0 ± 199.7 289.3 ± 149
TNF-α 12.2 ± 15.3 10.2 ± 11.6
  1. *all differences non-significant